sphebio

SPEBIO

SpeBio uses 3D bioprinting to enable cell aggregation
2020
Pohang, South Korea

Innovation

Industry Problem

Complex biological structures are difficult to create

R&D Focus

3D bioprinting

Innovative Solution

SPEBIO has developed a technology that uses 3D bioprinting to enable cell aggregation. It provides a platform technology that allows researchers to produce cell spheroids, aggregates, or clusters

Solution Effectiveness

Spebio’s technology platform can create complex biological structures using living cells, such as tissues and organs

Investment Funding

Last Funding Stage

Pre-seed

Last Funding Date

Sep 1, 2021

Startup Stage

Early-Stage

People

Founders

CEO

Products

Product

SphExo, BotanicExo

Demo Product or Complete Product?

Complete Product

Awards and Recognitions

Media Apperance

GreyB